Duvyzat®▼ (givinostat): interim advice on risk mitigation measures following reports of deaths in patients while taking givinostat

Synopsis

There have been several reports internationally of deaths in patients with Duchenne muscular dystrophy (DMD) while being treated with Duvyzat® (givinostat). Duvyzat®▼ (givinostat) is subject to additional monitoring.

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.